Björses P, Aaltonen J, Vikman A, Perheentupa J, Ben-Zion G, Chiumello G, Dahl N, Heideman P, Hoorweg-Nijman J J, Mathivon L, Mullis P E, Pohl M, Ritzen M, Romeo G, Shapiro M S, Smith C S, Solyom J, Zlotogora J, Peltonen L
Department of Molecular Genetics, National Public Health Institute, Helsinki, Finland.
Am J Hum Genet. 1996 Oct;59(4):879-86.
Autoimmune polyglandular disease type I (APECED) is an autosomal recessive autoimmune disease (MIM 240300) characterized by hypoparathyroidism, primary adrenocortical failure, and chronic mucocutaneous candidiasis. The disease is highly prevalent in two isolated populations, the Finnish population and the Iranian Jewish one. Sporadic cases have been identified in many other countries, including almost all European countries. The APECED locus has previously been assigned to chromosome 21q22.3 by linkage analyses in 14 Finnish families. Locus heterogeneity is a highly relevant question in this disease affecting multiple tissues and with great phenotypic diversity. To solve this matter, we performed linkage and haplotype analyses on APECED families rising from different populations. Six microsatellite markers on the critical chromosomal region of 2.6 cM on 21q22.3 were analyzed. Pairwise linkage analyses revealed significant LOD scores for all these markers, maximum LOD score being 10.23. The obtained haplotype data and the geographic distribution of the great-grandparents of the Finnish APECED patients suggest the presence of one major, relatively old mutation responsible for approximately 90% of the Finnish cases. Similar evidence for one founder mutation was also found in analyses of Iranian Jewish APECED haplotypes. These haplotypes, however, differed totally from the Finnish ones. The linkage analyses in 21 non-Finnish APECED families originating from several European countries provided independent evidence for linkage to the same chromosomal region on 21q22.3 and revealed no evidence for locus heterogeneity. The haplotype analyses of APECED chromosomes suggest that in different populations APECED is due to a spectrum of mutations in a still unknown gene on chromosome 21.
I型自身免疫性多腺体疾病(APECED)是一种常染色体隐性自身免疫性疾病(MIM 240300),其特征为甲状旁腺功能减退、原发性肾上腺皮质功能衰竭和慢性黏膜皮肤念珠菌病。该疾病在两个孤立人群中高度流行,即芬兰人群和伊朗犹太人群。在包括几乎所有欧洲国家在内的许多其他国家也发现了散发病例。此前通过对14个芬兰家庭的连锁分析,已将APECED基因座定位于21号染色体的21q22.3区域。基因座异质性在这种影响多个组织且具有高度表型多样性的疾病中是一个高度相关的问题。为了解决这个问题,我们对来自不同人群的APECED家庭进行了连锁和单倍型分析。分析了21q22.3上关键染色体区域2.6厘摩(cM)内的六个微卫星标记。成对连锁分析显示所有这些标记的LOD分数均显著,最大LOD分数为10.23。获得的单倍型数据以及芬兰APECED患者曾祖父母的地理分布表明,存在一个主要的、相对古老的突变,约90%的芬兰病例由其导致。在对伊朗犹太APECED单倍型的分析中也发现了一个奠基者突变的类似证据。然而,这些单倍型与芬兰的完全不同。对来自几个欧洲国家的21个非芬兰APECED家庭进行的连锁分析为与21q22.3上相同染色体区域的连锁提供了独立证据,且未发现基因座异质性的证据。APECED染色体的单倍型分析表明,在不同人群中,APECED是由21号染色体上一个仍未知基因中的一系列突变引起的。